Prebiotics, Probiotics & Synbiotics

SPREBIOTICS

Code Product Name Standardization Functional Activity
0565 Fenugreek Fibers
(Trigonella foenum-graecum)
FenuFibers®
50% Total Dietary Fiber
15% Protein
2.5% Steroidal Saponins
Blood sugar support
Cholesterol support
Glycemic index support
Support heart health
0570 Fenugreek Extract
(Trigonella foenum-graecum)
Fenumannans®
60% Galactomannan Blood sugar support
Digestive support
1944 Turmeric Starch (1) New
(Curcuma longa)
Starmeric®
40% Total Starch
20% Resistant Starch
Anti-inflammatory support
Gut Health
Prebiotic

SPROBIOTICS

Code Product Name Standardization Functional Activity
1205 Bacillus coagulans (MTCC 5856) (1,2,3) New
(Bacillus coagulans)
LactoSpore®
GRAS AFFIRMED
6 Billion Organisms/g Digestive support
Gastrointestinal health
General health
1200 Bacillus coagulans (MTCC 5856) (1,2,3) New
(Bacillus coagulans)
LactoSpore®
GRAS AFFIRMED
15 Billion Organisms/g Digestive support
Gastrointestinal health
General health
1201 Bacillus coagulans (MTCC 5856) (1,2,3) New
(Bacillus coagulans)
LactoSpore®
GRAS AFFIRMED
100 Billion Organisms/g Digestive support
Gastrointestinal health
General health
0909 ImmunoSpore New
(Bacillus coagulans MTCC 5856)
15 Billion spores/g count before heat inactivation
1,000 spores/g count after heat inactivation
Immune support

SSYNBIOTICS

Code Product Name Standardization Functional Activity
1206 LactoWise® 15 Billion Organisms/g
45% Galactomannan
5% Protein
Digestive support
Gastrointestinal health
General health
1101 LactoCran® (3) New 2 Billion Organisms/g
Organic Cranberry Seed/Juice
Digestive support
Gastrointestinal health
General health

SPATENTS

(1) LactoSpore® + Turmeric Starch (Starmeric )

US 10,323,227: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof

(2) LactoSpore®

US 10,668,115: Stable probiotic compositions containing Bacillus coagulans MTCC 5856 and method of detection thereof

US 10,609,935: Beverage compositions containing Bacillus coagulans MTCC 5856

US 9,579,352: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans

US 10,166,261; AU2016413572; CA3023818; ZL2019/00501: Bacillus coagulans MTCC 5856 for the management of major depressive disorder

US 10,260,112; CA2999517; EP3356545; MY-185340-A: Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856

EA037312; EP3240553; JP6629875; KR10-2157043;MY-182658-A; ZL 201680008035.7: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856

US 10,806,760: Compositions and methods for reducing flatulence

US 10,293,008; AU2015308650; EA034017; EP3185877;HK1233174; IDP000066793; JP6630723; KR10-2089566;MX376004; MY-174855-A; SG11201700006U;ZL201580042813.X: Process for enhancing the viable counts of lactic acid bacteria and useful composition thereof

US 10,792,295; JP6839329: Composition for management of Helicobacter pylori infection

RU2745755: Anti-pollution compositions containing Bacillus coagulans

(3) LactoCran®

US 9,717,766: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof

Disclaimer

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

    HEADQUARTERS

  • Sabinsa Corporation
    20 Lake Drive
    East Windsor
    NJ 08520, USA

  • +1 732 777 1111
  • +1 732 777 1443
  • info@sabinsa.com

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US